Skip to main content
. 2022 Mar 15;49(5):66. doi: 10.3892/ijmm.2022.5122

Figure 9.

Figure 9

Model of CYLD deficiency in melanoma cells. The upregulation of EHMT2 and associated di-methylation of H3K9 leads to heterochromatin and the induction of proliferation of proliferation. CM272, which inhibits the activity of EHMT2. The associated decrease in H3K9me2 levels results in loosening of chromatin and decreased proliferation of CYLD-deficient melanoma cells (abstracted and modified from smart.servier.com/). EHMT2, euchromatic histone lysine methyltransferase 2; CYLD, CYLD lysine 63 deubiquitinase.